In 2023, David M. Epstein, Ph.D. earned $2.02M in total compensation at Black Diamond Therapeutics, Inc., including $412.30K salary and $1.05M bonus. Most recently sold 25,000 shares in Jun 2023. Currently holds stock worth $1.94M. Led Black Diamond Therapeutics, Inc. as CEO for 3 years.
Compensation History
Annual executive compensation data for David M. Epstein, Ph.D., including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$2.02M
Salary
$412.30K
Bonus
$1.05M
Other
$557.39K
Salary
$412.30KBoard Justification
The compensation philosophy is based on a pay-for-performance model, aligning executive compensation with company performance and market benchmarks.
Bonus
$1.05MBoard Justification
Dr. Epstein's separation agreement provided him with a cash amount equal to his target bonus for 2023, as he resigned prior to the payment date.
Other Compensation
$557.39KBoard Justification
This includes severance and vacation payout amounts of $489,909 and $48,141, respectively.
Restricted Stock
Board Justification
No stock was reported as vested in 2023.
Performance Metrics
The performance metrics for determining compensation include achievement of company and individual performance goals.
David M. Epstein, Ph.D.
Ex-CEO of Black Diamond Therapeutics, Inc.
Education
Ph.D. in a relevant field
Field of Expertise
Healthcare & Life Sciences - Biotechnology
Sector of Economy
Healthcare
Born
January 1, 1973 - 52 years ago
CEO of Black Diamond Therapeutics, Inc. for
3 years 8 months (Jan 2020 - Sep 2023)
Previous Experience
Former CEO of a biotechnology company
Other Black Diamond Therapeutics, Inc. CEOs
Holdings
Track David M. Epstein, Ph.D.'s stock holdings and portfolio value over time.
Total Stock Sold
$1.67M
$1.67M
73,000 BDTX shares
What if they kept their stock?
If David M. Epstein, Ph.D. didn't sell their stock, today they would have:
Extra BDTX73,000 shares worth $203.67K.
This is -87.84% and $1.47M less than what they got when they sold the stock.
Insider Trading
David M. Epstein, Ph.D.'s recent stock transactions, purchases, and sales filed with the SEC.
$167.50K
BDTX at $6.70/share
Jun 27, 2023
Sale
$376.73K
BDTX at $31.39/share
Jan 4, 2021
Sale
$396.53K
BDTX at $33.04/share
Dec 1, 2020
Sale
$378.05K
BDTX at $31.50/share
Nov 2, 2020
Sale
$363.96K
BDTX at $30.33/share
Oct 1, 2020
Sale
Rivals
Compare David M. Epstein, Ph.D. with competitor CEOs and industry peers.